|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Bordetella pertussis IgG ELISA | ACTH ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Lysozyme ELISA Assay |
| Catalog Number | IB05011 | BM7023 | TM09021 | TM09036 | IB19131 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgG antibodies in serum or plasma directed against Bordetella pertussis and Bordetella parapertussis. For research use only, not for use in diagnostic procedures. | Enzyme-linked immunosorbent assay (ELISA) for the determination of ACTH (Adrenocorticotropic Hormone) in human plasma. 510(k) cleared. This assay is intended for in-vitro diagnostic use. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase direct sandwich ELISA for the determination of Lysozyme in human plasma, serum, or stool. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Bordetella pertussis IgG | Amyloid Beta (1-x) | S100B | sAPP Total | Human T-Cadherin(130K) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Blood Plasma, CSF, Serum, Cell Culture Media, Extract from Brain Tissue | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 5 to 165 pg/mL | 0 / 6 to 200 ng/mL | Anti-Ustekinumab (Stelara®) | 0.1 to 40.0 ng/mL |
| Sensitivity | > 96% | 3.55 pg/mL | Inquire | 0.06 ng/mL | 0.01 ng/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 4 hrs 30 mins (incubation) | 2 hours, 10 min. total incubation time. | 2 hour, 30 min. total incubation time. | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |